Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: A preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progression.
Pak J Pharm Sci
; 32(3 Special): 1293-1299, 2019 May.
Article
en En
| MEDLINE
| ID: mdl-31551206
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Biomarcadores
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias Pulmonares
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Adult
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2019
Tipo del documento:
Article